Calcium-dependent plasma membrane repair requires m- or μ-calpain, but not calpain-3, the proteasome, or caspases

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 12, 2009, Pages 1886-1893

  Mellgren, Ronald L ^a   Miyake, Katsuya ^b   Kramerova, Irina ^c   Spencer, Melissa J ^c   Bourg, Nathalie ^d   Bartoli, Marc ^d   Richard, Isabelle ^d   Greer, Peter A ^e   McNeil, Paul L ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CNRS   (France)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

Calpain; Caspase; Membrane repair; Proteasome

Indexed keywords

CALCIUM ION; CALPAIN 1; CALPAIN 2; CALPAIN 3; CASPASE; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; FIBROBLAST; FLEXOR MUSCLE; MEMBRANE DAMAGE; MOUSE; MUSCLE CELL; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; SARCOLEMMA;

MUS;

EID: 71749109832     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2009.09.013     Document Type: Article

References (43)

1. McNeil P.L., and Steinhardt R.A. Plasma membrane disruption: repair, prevention, adaptation. Annu. Rev. Cell Dev. Biol. 19 (2003) 697-731
2. McNeil P.L., and Kirchhausen T. An emergency response team for membrane repair. Nat. Rev. Mol. Cell Biol. 6 (2005) 499-505
3. Han R., Bansal D., Miyake K., Muniz V.P., Weiss R.M., McNeil P.L., and Campbell K.P. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J. Clin. Invest 117 (2007) 1805-1813
4. McNeil P.L., and Khakee R. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am. J. Pathol. 140 (1992) 1097-1109
5. Fischer T.A., McNeil P.L., Khakee R., Finn P., Kelly R.A., Pfeffer M.A., and Pfeffer J.M. Cardiac myocyte membrane wounding in the abruptly pressure-overloaded rat heart under high wall stress. Hypertension 30 (1997) 1041-1046
6. Bi G.Q., Alderton J.M., and Steinhardt R.A. Calcium-regulated exocytosis is required for cell membrane resealing. J. Cell Biol. 131 (1995) 1747-1758
7. Bansal D., Miyake K., Vogel S.S., Groh S., Chen C.C., Williamson R., McNeil P.L., and Campbell K.P. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423 (2003) 168-172
8. Wenzel K., Geier C., Qadri F., Hubner N., Schulz H., Erdmann B., Gross V., Bauer D., Dechend R., Dietz R., et al. Dysfunction of dysferlin-deficient hearts. J. Mol. Med. 85 (2007) 1203-1214
9. McNeil A.K., Rescher U., Gerke V., and McNeil P.L. Requirement for annexin A1 in plasma membrane repair. J. Biol. Chem. 281 (2006) 35202-35207
10. Mellgren R.L., Zhang W., Miyake K., and McNeil P.L. Calpain is required for the rapid, calcium-dependent repair of wounded plasma membrane. J. Biol. Chem. 282 (2007) 2567-2575
11. Mellgren R.L., and Huang X. Fetuin A stabilizes m-calpain and facilitates plasma membrane repair. J. Biol. Chem. 282 (2007) 35868-35877
12. Richard I., Broux O., Allamand V., Fougerousse F., Chiannilkulchai N., Bourg N., Brenguier L., Devaud C., Pasturaud P., Roudaut C., et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81 (1995) 27-40
13. Huang Y., Verheesen P., Roussis A., Frankhuizen W., Ginjaar I., Haldane F., Laval S., Anderson L.V., Verrips T., Frants R.R., et al. Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display. Eur. J. Hum. Genet. 13 (2005) 721-730
14. Laure L., Suel L., Roudaut C., Bourg N., Ouali A., Bartoli M., Richard I., and Danièle N. Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling. FEBS J. 276 (2009) 669-684
15. Raser K.J., Posner A., and Wang K.K. Casein zymography: a method to study mu-calpain, m-calpain, and their inhibitory agents. Arch. Biochem. Biophys. 319 (1995) 211-216
16. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150 (1985) 76-85
17. Mellgren R.L. Proteolysis of nuclear proteins by mu-calpain and m-calpain. J. Biol. Chem. 266 (1991) 13920-13924
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65 (1983) 55-63
19. Miyake K., McNeil P.L., Suzuki K., Tsunoda R., and Sugai N. An actin barrier to resealing. J. Cell Sci. 114 (2001) 3487-3494
20. Kramerova I., Kudryashova E., Tidball J.G., and Spencer M.J. Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. Hum. Mol. Genet. 13 (2004) 1373-1388
21. Dourdin N., Bhatt A.K., Dutt P., Greer P.A., Arthur J.S., Elce J.S., and Huttenlocher A. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J. Biol. Chem. 276 (2001) 48382-48388
22. Franco S., Perrin B., and Huttenlocher A. Isoform specific function of calpain 2 in regulating membrane protrusion. Exp. Cell Res. 299 (2004) 179-187
23. Sorimachi H., Kinbara K., Kimura S., Takahashi M., Ishiura S., Sasagawa N., Sorimachi N., Shimada H., Tagawa K., Maruyama K., et al. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J. Biol. Chem. 270 (1995) 31158-31162
24. Huebsch K.A., Kudryashova E., Wooley C.M., Sher R.B., Seburn K.L., Spencer M.J., and Cox G.A. Mdm muscular dystrophy: interactions with calpain 3 and a novel functional role for titin's N2A domain. Hum. Mol. Genet. 14 (2005) 2801-2811
25. Glover L., and Brown Jr. R.H. Dysferlin in membrane trafficking and patch repair. Traffic 8 (2007) 785-794
26. Murphy R.M., and Lamb G.D. Endogenous calpain-3 activation is primarily governed by small increases in resting cytoplasmic [Ca2+] and is not dependent of stretch. J. Biol. Chem. 284 (2009) 7811-7819
27. Taveau M., Bourg N., Sillon G., Roudaut C., Bartoli M., and Richard I. Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol. Cell Biol. 23 (2003) 9127-9135
28. Guyon J.R., Kudryashova E., Potts A., Dalkilic I., Brosius M.A., Thompson T.G., Beckmann J.S., Kunkel L.M., and Spencer M.J. Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta-sarcoglycans. Muscle Nerve 28 (2003) 472-483
29. Kramerova I., Kudryashova E., Wu B., and Spencer M.J. Regulation of the M-cadherin-beta-catenin complex by calpain 3 during terminal stages of myogenic differentiation. Mol. Cell Biol. 26 (2006) 8437-8447
30. Chiarle R., Budel L.M., Skolnik J., Frizzera G., Chilosi M., Corato A., Pizzolo G., Magidson J., Montagnoli A., Pagano M., et al. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood 95 (2000) 619-626
31. McCracken A.A., and Brodsky J.L. Recognition and delivery of ERAD substrates to the proteasome and alternative paths for cell survival. Curr. Top Microbiol. Immunol. 300 (2005) 17-40
32. Seo H., Sonntag K.C., Kim W., Cattaneo E., and Isacson O. Proteasome activator enhances survival of Huntington's disease neuronal model cells. PLoS ONE 2 (2007) e238
33. Keller M., Ruegg A., Werner S., and Beer H.D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132 (2008) 818-831
34. Gurcel L., Abrami L., Girardin S., Tschopp J., and van der Goot F.G. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126 (2006) 1135-1145
35. Chowdary D.R., Dermody J.J., Jha K.K., and Ozer H.L. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell Biol. 14 (1994) 1997-2003
36. Dutt P., Croall D.E., Arthur J.S., Veyra T.D., Williams K., Elce J.S., and Greer P.A. m-Calpain is required for preimplantation embryonic development in mice. BMC Dev. Biol. 6 (2006) 3
37. Goll D.E., Thompson V.F., Li H., Wei W., and Cong J. The calpain system. Physiol. Rev. 83 (2003) 731-801
38. Spencer M.J., Lu B., and Tidball J.G. Calpain II expression is increased by changes in mechanical loading of muscle in vivo. J. Cell Biochem. 64 (1997) 55-66
39. Anderson L.V., Harrison R.M., Pogue R., Vafiadaki E., Pollitt C., Davison K., Moss J.A., Keers S., Pyle A., Shaw P.J., et al. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul. Disord. 10 (2000) 553-559
40. Ojima K., Ono Y., Doi N., Yoshioka K., Kawabata Y., Labeit S., and Sorimachi H. Myogenic stage, sarcomere length, and protease activity modulate localization of muscle-specific calpain. J. Biol. Chem. 282 (2007) 14493-14504
41. Murphy R.M., Goodman C.A., McKenna M.J., Bennie J., Leikis M., and Lamb G.D. Calpain-3 is autolyzed and hence activated in human skeletal muscle 24 h following a single bout of eccentric exercise. J. Appl. Physiol. 103 (2007) 926-931
42. Huang Y., de Morree A., van Remoortere A., Bushby K., Frants R.R., Dunnen J.T., and van der Maarel S.M. Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. Hum. Mol. Genet. 17 (2008) 1855-1866
43. Feasson L., Stockholm D., Freyssenet D., Richard I., Duguez S., Beckmann J.S., and Denis C. Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle. J. Physiol. 543 (2002) 297-306